Cantourage is a publicly listed, leading European medical cannabis company. The Berlin-based company with subsidiaries in the United Kingdom and Poland, was founded in 2019 by industry pioneers Norman Ruchholtz, Dr. Florian Holzapfel and Patrick Hoffmann. Cantourage enables producers from all over the world to become part of the rapidly growing European medical cannabis market in a faster and more cost-effective way, while guaranteeing and developing the highest European quality standards. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol and pharma-grade Cannabidiol. The company was listed on the Frankfurt Stock Exchange on 11 November 2022 and is listed under the stock ticker “HIGH”.
First trading day | 11/11/2022 |
Securities identification number | A3DSV0 |
ISIN | DE000A3DSV01 |
LEI | 3912003NCTLO6YHA9V48 |
Ticker Symbol | HIGH |
Segment | Scale |
Market | Open Market |
Trading venues | XETRA, Frankfurt (Scale), Open Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange |
Class of shares | Bearer shares |
Share capital in EUR | 12,467,479.00 |
Number of shares | 12,467,479 |
Designated Sponsor | Hauck Aufhäuser/mwb fairtrade Wertpapierhandelsbank, both Frankfurt am Main |
Specialist | WOLFGANG STEUBING AG |
Paying agent | Hauck Aufhäuser Lampe Privatbank AG, Kaiserstrasse 24, 60311 Frankfurt am Main |
Financial year | 1 January to 31 December |